SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001819790-24-000081
Filing Date
2024-06-14
Accepted
2024-06-14 17:40:44
Documents
3
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718401236.html 4  
1 FORM 4 wk-form4_1718401236.xml 4 6514
2 EX-24 tarsus-powerofattorneyro.htm EX-24 644
3 tarsus-powerofattorneyro001.jpg GRAPHIC 300906
  Complete submission text file 0001819790-24-000081.txt   423152
Mailing Address C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address
Crane Rosemary A (Reporting) CIK: 0001443343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 241046202

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)